# Attenuation of Airway and Cardiovascular Responses to Extubation in Chronic Smokers

> **NCT04659642** · EARLY_PHASE1 · UNKNOWN · sponsor: **National Cancer Institute, Egypt** · enrollment: 66 (estimated)

## Conditions studied

- Airway Responses
- Hemodynamic

## Interventions

- **DRUG:** Dexmedetomidine Injection [Precedex]
- **DRUG:** Fentanyl Citrate Injection
- **COMBINATION_PRODUCT:** dexmedetomidine and fentanyl

## Key facts

- **NCT ID:** NCT04659642
- **Lead sponsor:** National Cancer Institute, Egypt
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-11-30
- **Primary completion:** 2021-03-06
- **Final completion:** 2021-03-20
- **Target enrollment:** 66 (ESTIMATED)
- **Last updated:** 2021-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04659642

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04659642, "Attenuation of Airway and Cardiovascular Responses to Extubation in Chronic Smokers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04659642. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*